This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
RSV | 6313 |
SARS | 4388 |
PCR | 2457 |
CoV | 2236 |
MERS | 2067 |
el | 1570 |
RNA | 1431 |
COVID-19 | 1399 |
ARDS | 1136 |
A | 1098 |
HRV | 1051 |
East | 948 |
Middle | 927 |
ICU | 919 |
Fig | 904 |
los | 901 |
HBoV | 866 |
China | 778 |
RT | 777 |
C | 775 |
parainfluenza | 767 |
PRRSV | 740 |
CoV-2 | 735 |
B | 725 |
con | 688 |
IFN | 685 |
Human | 668 |
mg | 667 |
Coronavirus | 660 |
T | 659 |
Respiratory | 658 |
Health | 655 |
RV | 637 |
Influenza | 628 |
para | 615 |
Table | 608 |
H1N1 | 596 |
metapneumovirus | 591 |
COPD | 576 |
United | 570 |
II | 565 |
del | 555 |
HCoV | 551 |
un | 510 |
ARI | 491 |
• | 488 |
States | 484 |
S. | 472 |
Disease | 469 |
PIV | 438 |
Syndrome | 436 |
M. | 429 |
Hospital | 428 |
HMPV | 425 |
OC43 | 424 |
F | 419 |
pacientes | 415 |
las | 414 |
una | 403 |
kg | 392 |
en | 377 |
USA | 358 |
Group | 352 |
NL63 | 349 |
Saudi | 344 |
M | 337 |
Arabia | 336 |
Hong | 331 |
Hajj | 331 |
S | 327 |
sha | 326 |
Kong | 319 |
HIV | 317 |
CI | 306 |
CT | 302 |
Care | 301 |
University | 298 |
Se | 294 |
FilmArray | 292 |
World | 290 |
TB | 290 |
como | 284 |
US | 276 |
por | 271 |
HKU1 | 268 |
bocavirus | 267 |
Viral | 262 |
CD4 | 262 |
HRSV | 261 |
DNA | 256 |
Control | 256 |
LRTI | 251 |
Society | 249 |
ILI | 249 |
CD8 | 247 |
Organization | 245 |
Korea | 245 |
DOI | 243 |
South | 242 |
National | 238 |
January | 238 |
Rhinovirus | 237 |
Research | 236 |
J | 232 |
virus | 230 |
es | 229 |
L | 228 |
December | 224 |
CDC | 222 |
der | 221 |
meta | 219 |
Virus | 217 |
Study | 215 |
IL-6 | 215 |
PICU | 214 |
ED | 213 |
Detection | 213 |
March | 208 |
Prevention | 207 |
Medical | 206 |
Association | 205 |
N | 205 |
ACE2 | 204 |
Committee | 204 |
La | 203 |
uso | 202 |
IV | 201 |
Clinical | 199 |
Mycoplasma | 198 |
Infectious | 198 |
ECMO | 198 |
Children | 197 |
B. | 197 |
Diseases | 195 |
airways | 194 |
D | 194 |
C. | 192 |
New | 192 |
recomienda | 189 |
MPV | 186 |
Adenovirus | 185 |
TNF | 184 |
H5N1 | 183 |
ALI | 183 |
UK | 182 |
April | 182 |
Lung | 181 |
Japan | 181 |
bronchiolitis | 180 |
Germany | 178 |
Center | 176 |
Staphylococcus | 176 |
hMPV | 176 |
uenza | 175 |
HSCT | 175 |
September | 174 |
Africa | 174 |
SARI | 172 |
May | 171 |
HA | 171 |
CMV | 171 |
June | 170 |
Italy | 168 |
HPIV | 167 |
IgA | 166 |
< | 166 |
Intensive | 165 |
Evaluation | 164 |
Canada | 164 |
G | 163 |
Streptococcus | 162 |
su | 160 |
P. | 160 |
America | 157 |
bronchoalveolar | 156 |
Europe | 155 |
Institute | 153 |
Australia | 153 |
L. | 152 |
July | 152 |
N95 | 151 |
IgG | 151 |
Singapore | 151 |
IL-10 | 150 |
Pediatric | 150 |
Wuhan | 149 |
International | 149 |
October | 148 |
ventilación | 147 |
IL-8 | 146 |
WHO | 145 |
puede | 144 |
infl | 143 |
Epidemiology | 142 |
Chlamydia | 141 |
ADV | 141 |
FEV | 141 |
α | 141 |
Bronchiolitis | 140 |
LRI | 140 |
IgE | 139 |
I | 137 |
France | 137 |
Community | 137 |
III | 136 |
February | 136 |
RP | 136 |
El | 135 |
Asia | 135 |
fi | 134 |
November | 134 |
NK | 134 |
Parainfluenza | 132 |
ser | 132 |
van | 131 |
R | 131 |
Infection | 131 |
sera | 131 |
Department | 130 |
Netherlands | 129 |
CO | 129 |
Ebola | 128 |
paciente | 127 |
Review | 127 |
Infections | 127 |
H. | 127 |
ELISA | 126 |
catarrhalis | 125 |
Medicine | 124 |
Inc. | 124 |
fl | 124 |
nan | 124 |
Pneumonia | 122 |
Mycobacterium | 122 |
HBoV-1 | 121 |
American | 121 |
Treatment | 120 |
Fisher | 120 |
URI | 119 |
LRT | 119 |
CNS | 119 |
CA | 119 |
M2 | 118 |
lo | 118 |
Unit | 118 |
City | 117 |
CoV. | 117 |
AMCI | 115 |
Management | 114 |
E. | 114 |
von | 114 |
Molecular | 114 |
diagnóstico | 113 |
CoVs | 113 |
enfermedad | 113 |
tratamiento | 112 |
UCI | 112 |
Score | 112 |
NS | 112 |
HAdV | 112 |
estudios | 111 |
DC | 111 |
riesgo | 111 |
S1 | 110 |
K | 110 |
min | 109 |
IL-4 | 109 |
EV | 109 |
Development | 109 |
System | 108 |
Novel | 108 |
Legionella | 108 |
HCT | 107 |
BRSV | 107 |
Asthma | 107 |
Centers | 107 |
~ | 107 |
Taiwan | 107 |
mortalidad | 106 |
debe | 106 |
MRSA | 106 |
HCoV-229E | 106 |
BAL | 106 |
Analysis | 106 |
AHR | 106 |
PRRS | 105 |
FDA | 105 |
Laboratory | 105 |
North | 105 |
RTI | 105 |
estudio | 105 |
más | 105 |
Global | 104 |
Thailand | 103 |
Med | 103 |
Impact | 103 |
IVIG | 103 |
CAP | 103 |
APACHE | 103 |
URTI | 102 |
URT | 102 |
NP | 102 |
CPB | 101 |
Beijing | 101 |
se | 101 |
Qiagen | 100 |
E | 100 |
AE | 100 |
manejo | 100 |
PEEP | 100 |
IgM | 99 |
Flu | 99 |
γ | 99 |
CPAP | 98 |
CF | 98 |
J. | 97 |
Effect | 97 |
Brazil | 97 |
Efficacy | 96 |
Acute | 96 |
Bordetella | 96 |
NPA | 96 |
mRNA | 96 |
Rapid | 96 |
pH | 95 |
SDRA | 95 |
Moraxella | 95 |
oseltamivir | 94 |
Bocavirus | 94 |
vivo | 93 |
Severity | 93 |
European | 93 |
Pseudomonas | 92 |
India | 92 |
Figure | 91 |
días | 91 |
Mexico | 91 |
H3N2 | 90 |
H | 90 |
DCs | 90 |
Surveillance | 90 |
enteroviruses | 89 |
Th2 | 89 |
Syncytial | 89 |
HCoVs | 89 |
FRC | 89 |
palivizumab | 88 |
SPSS | 88 |
Paramyxoviridae | 87 |
IQR | 87 |
MV | 87 |
azithromycin | 87 |
VP1 | 87 |
lymphopenia | 87 |
mecánica | 87 |
_ | 86 |
ViVI | 86 |
Use | 86 |
Spain | 86 |
England | 86 |
U.S. | 85 |
MMP-9 | 85 |
IL-12 | 85 |
ICAM-1 | 85 |
A. | 84 |
Rhinoviruses | 84 |
RVP | 84 |
R. | 83 |
Protein | 83 |
sospecha | 83 |
Toronto | 83 |
eine | 83 |
defi | 82 |
entre | 81 |
einer | 81 |
Guidelines | 81 |
monocyte | 80 |
Respir | 80 |
Republic | 80 |
Lee | 80 |
FRI | 80 |
D. | 79 |
Pneumocystis | 79 |
GenBank | 79 |
Patients | 78 |
Klebsiella | 78 |
Emergency | 78 |
August | 78 |
® | 77 |
signifi | 77 |
obliterans | 77 |
V | 77 |
Kingdom | 77 |
IC | 77 |
Los | 76 |
I. | 76 |
hCoV | 76 |
mayor | 76 |
han | 76 |
sobre | 75 |
respiratoria | 75 |
Risk | 75 |
NF | 75 |
Haemophilus | 75 |
AIDS | 75 |
Pasteurella | 74 |
Chi | 74 |
Coronaviruses | 74 |
Network | 74 |
IL | 74 |
Wang | 74 |
casos | 74 |
den | 74 |
type | 74 |
pulmonar | 73 |
intubación | 73 |
esta | 73 |
Viruses | 73 |
S2 | 73 |
Panel | 73 |
Luminex | 73 |
CRP | 73 |
BOS | 73 |
Dis | 72 |
Ministry | 72 |
U | 72 |
airway | 72 |
alta | 72 |
pueden | 72 |
cuidados | 71 |
IL-18 | 71 |
Ethics | 71 |
Diagnostics | 71 |
Chronic | 71 |
Transmission | 70 |
CSF | 70 |
RDS | 70 |
Centre | 70 |
grupo | 70 |
infección | 70 |
β | 70 |
fue | 69 |
RVI | 69 |
Patient | 69 |
PPE | 69 |
PIV-3 | 69 |
K. | 69 |
IL-13 | 69 |
Applied | 69 |
IBC | 68 |
Central | 68 |
Guangdong | 68 |
ARF | 68 |
SP | 68 |
tachypnea | 68 |
pneumovirus | 68 |
polyomavirus | 67 |
identifi | 67 |
WU | 67 |
NIV | 67 |
G. | 67 |
Metapneumovirus | 66 |
Al | 66 |
Biosystems | 66 |
MD | 66 |
DPP4 | 66 |
PIV3 | 66 |
Public | 66 |
VAP | 66 |
Virology | 66 |
nan | 66 |
Assessment | 65 |
BALB | 65 |
BALF | 65 |
BPD | 65 |
Identification | 65 |
RANTES | 65 |
ed | 65 |
personal | 65 |
presión | 65 |
TM | 64 |
HSV | 64 |
Mann | 64 |
Pulmonary | 64 |
Diagnosis | 64 |
coryza | 64 |
evidencia | 64 |
multicentre | 64 |
día | 64 |
κB | 63 |
east | 63 |
RR | 63 |
Pandemic | 63 |
Northern | 63 |
IFV | 63 |
Coronaviridae | 63 |
Li | 62 |
A2 | 62 |
Administration | 62 |
H20 | 62 |
HEV | 62 |
ICP | 62 |
MOF | 62 |
Thoracic | 62 |
ammatory | 62 |
MHC | 62 |
hBoV | 62 |
Distress | 61 |
este | 61 |
des | 61 |
IL-1 | 61 |
HAdVs | 61 |
DFA | 61 |
Critical | 61 |
College | 61 |
ALRI | 61 |
EBOV | 60 |
Report | 60 |
8) | 60 |
MAP | 60 |
York | 60 |
Vietnam | 60 |
hyperresponsiveness | 60 |
tiempo | 60 |
zanamivir | 59 |
specifi | 59 |
salud | 59 |
Whitney | 59 |
Southern | 59 |
Senegal | 59 |
RI-002 | 59 |
Qigong | 59 |
Pediatrics | 59 |
Jordan | 59 |
Nipah | 58 |
HAdV-55 | 58 |
P | 58 |
clínico | 58 |
mit | 58 |
Pathogenesis | 57 |
PA | 57 |
hRV | 56 |
IFA | 56 |
Effectiveness | 56 |
Chlamydophila | 56 |
Arabian | 56 |
MMP-8 | 55 |
ARTI | 55 |
GM | 55 |
Guangzhou | 55 |
IAV | 55 |
Palivizumab | 55 |
Peninsula | 55 |
clínica | 55 |
horas | 55 |
soporte | 55 |
Meta | 54 |
BCoV | 54 |
CIRD | 54 |
CVP | 54 |
NATs | 54 |
NMD | 54 |
Province | 54 |
Vero | 54 |
menor | 54 |
multocida | 54 |
empyema | 53 |
ABPC | 53 |
Drug | 53 |
Foundation | 53 |
Zealand | 53 |
si | 53 |
hexon | 53 |
infi | 53 |
mm | 53 |
und | 53 |
Ribavirin | 52 |
Associated | 52 |
CCL5 | 52 |
Clara | 52 |
Dr. | 52 |
PSV | 52 |
SD | 52 |
Riyadh | 52 |
State | 52 |
alto | 52 |
hRSV | 52 |
síntomas | 52 |
Las | 51 |
A(H1N1)pdm09 | 51 |
BCG | 51 |
H1N1v | 51 |
H7N9 | 51 |
Hg | 51 |
Index | 51 |
LV | 51 |
Malaysia | 51 |
RCT | 51 |
Safety | 51 |
VI | 51 |
bajo | 51 |
cols | 51 |
fueron | 51 |
pero | 51 |
| | 51 |
ECG | 50 |
Neutrophil | 50 |
IL-5 | 50 |
HCWs | 50 |
Sweden | 50 |
De | 50 |
Comparison | 50 |
CTL | 50 |
AOM | 50 |
Rhodococcus | 50 |
zu | 50 |
VN | 50 |
cuenta | 50 |
doc_id | 50 |
dosis | 50 |
kg/3 | 50 |
nucleocapsid | 50 |
protección | 50 |
respiratorio | 50 |
aguda | 50 |
High | 49 |
Chen | 49 |
VC | 49 |
Illness | 49 |
Serologic | 48 |
Box | 48 |
Case | 48 |
KSA | 48 |
Multiplex | 48 |
RdRp | 48 |
ritonavir | 48 |
Virol | 48 |
atención | 48 |
bronchiseptica | 48 |
haemolytica | 48 |
¼ | 48 |
H3 | 47 |
BALT | 47 |
CPR | 47 |
Clin | 47 |
RV16 | 47 |
son | 47 |
hasta | 47 |
realizar | 47 |
sec | 47 |
hCoVs | 47 |
TLR4 | 46 |
Air | 46 |
Board | 46 |
Escherichia | 46 |
Healthcare | 46 |
Institutional | 46 |
KI | 46 |
Kim | 46 |
Microbiology | 46 |
PE | 46 |
Zhang | 46 |
clínicos | 46 |
contra | 46 |
deben | 46 |
nivel | 46 |
pandemia | 46 |
rhinorrhea | 46 |
werden | 46 |
Vaccine | 46 |
Childhood | 45 |
GA | 45 |
RI-001 | 45 |
Chicago | 45 |
Adults | 45 |
Mannheimia | 45 |
oxígeno | 45 |
Roche | 45 |
inicio | 45 |
intensivos | 45 |
oxigenación | 45 |
⁄ | 45 |
compromiso | 45 |
IL-33 | 44 |
Cancer | 44 |
D68 | 44 |
EEG | 44 |
Gene | 44 |
Host | 44 |
F. | 44 |
Kenya | 44 |
ribavirin | 44 |
ORF | 44 |
Obiectives | 44 |
TRS | 44 |
MS | 44 |
IL-1β | 43 |
Food | 43 |
FVC | 43 |
En | 43 |
ETT | 43 |
Cochrane | 43 |
Data | 43 |
Cell | 43 |
Burden | 43 |
ACE | 43 |
LA | 43 |
Ill | 43 |
críticos | 43 |
LLC | 43 |
mejoría | 43 |
± | 43 |
severa | 43 |
rst | 43 |
PCV2 | 43 |
niveles | 43 |
West | 43 |
TLC | 43 |
Structure | 43 |
Scientific | 43 |
Picornaviridae | 43 |
Bangladesh | 42 |
CRCoV | 42 |
Therapy | 42 |
RSC | 42 |
Science | 42 |
PRISM | 42 |
VT | 42 |
interleukin-8 | 42 |
mL | 42 |
otros | 42 |
vía | 42 |
cual | 42 |
LOS | 41 |
AMI | 41 |
Antibody | 41 |
BP | 41 |
CXR | 41 |
EIA | 41 |
HAdV-3 | 41 |
LAIV | 41 |
GP5 | 41 |
LPS | 41 |
Protection | 41 |
SH | 41 |
San | 41 |
Severe | 41 |
TaqMan | 41 |
lopinavir | 41 |
terapia | 41 |
PIV1 | 41 |
Heart | 40 |
NS2 | 40 |
Mini | 40 |
Mechanisms | 40 |
Immune | 40 |
IRF3 | 40 |
Allander | 40 |
Hall | 40 |
Enterovirus | 40 |
Collins | 40 |
ANOVA | 40 |
ResPlex | 40 |
PCT | 40 |
Western | 40 |
RespiGam | 40 |
influenza | 40 |
todos | 40 |
SAPS | 40 |
ned | 40 |
lavage | 40 |
ingreso | 40 |
resultados | 40 |
control | 40 |
Vt | 40 |
UTR | 40 |
Surfactant | 40 |
SCD | 40 |
Mortality | 39 |
BVDV | 39 |
Berlin | 39 |
California | 39 |
Dr | 39 |
E- | 39 |
EAV | 39 |
EMC | 39 |
Fast | 39 |
Ghana | 39 |
Liu | 39 |
GP | 39 |
PIV-1 | 39 |
cmH20 | 39 |
QIAamp | 39 |
range | 39 |
nucleoprotein | 39 |
durante | 39 |
pronóstico | 39 |
Technology | 39 |
Sciences | 39 |
Response | 39 |
seguridad | 39 |
Journal | 38 |
CARV | 38 |
CS | 38 |
Chinese | 38 |
ERV3 | 38 |
HR | 38 |
Japanese | 38 |
IL-2 | 38 |
NICU | 38 |
confi | 38 |
dos | 38 |
middle | 38 |
ml | 38 |
recursos | 38 |
severo | 38 |
PaO2 | 37 |
Toll | 37 |
Taxonomy | 37 |
TLR3 | 37 |
Sendai | 37 |
Practice | 37 |
Eccles | 37 |
Niger | 37 |
N. | 37 |
WBC | 37 |
EBV | 37 |
Airway | 37 |
AHRF | 37 |
Van | 37 |
flujo | 37 |
chi | 37 |
protein | 37 |
convaleciente | 37 |
␣ | 37 |
vida | 37 |
utilizar | 37 |
recibieron | 37 |
tipo | 37 |
lung | 37 |
ltrates | 37 |
falla | 37 |
estrategia | 37 |
decisiones | 37 |
NO | 36 |
Koch | 36 |
Kg | 36 |
Investigation | 36 |
Harbin | 36 |
Emirates | 36 |
Academy | 36 |
EVD | 36 |
DAS181 | 36 |
CoV2 | 36 |
CPE | 36 |
CO2 | 36 |
BII | 36 |
MK2 | 36 |
baja | 36 |
School | 36 |
durch | 36 |
sido | 36 |
realización | 36 |
número | 36 |
infecciones | 36 |
effi | 36 |
Seegene | 36 |
donde | 36 |
V. | 36 |
TGF | 36 |
Seoul | 36 |
Working | 36 |
HRVs | 35 |
Outbreak | 35 |
King | 35 |
Inf | 35 |
Induction | 35 |
Immunization | 35 |
Glasgow | 35 |
Greece | 35 |
PS | 35 |
FEV1 | 35 |
ET | 35 |
EPP | 35 |
CLD | 35 |
Advisory | 35 |
PAF | 35 |
Life | 35 |
mmHg | 35 |
bei | 35 |
sugiere | 35 |
Pediatr | 35 |
menos | 35 |
manera | 35 |
immunodefi | 35 |
hipoxemia | 35 |
crítico | 35 |
PaO | 35 |
amoxicillin | 35 |
Recovery | 35 |
QM | 35 |
PubMed | 35 |
Prodesse | 35 |
Pleural | 35 |
TLR | 35 |
HCQ | 34 |
John | 34 |
Isolation | 34 |
Iran | 34 |
HPyV6 | 34 |
HCV | 34 |
Chest | 34 |
GCS | 34 |
Es | 34 |
Cardiac | 34 |
Arab | 34 |
Animal | 34 |
RFP | 34 |
ROC | 34 |
SS | 34 |
desde | 34 |
Type | 34 |
posición | 34 |
human | 34 |
hepatitis | 34 |
equipo | 34 |
cuales | 34 |
coronaviruses | 34 |
ciency | 34 |
bp | 34 |
benefi | 34 |
Diagnostic | 33 |
IBV | 33 |
HFNC | 33 |
Finland | 33 |
ER | 33 |
ABI | 33 |
CXCL10 | 33 |
Blood | 33 |
B19 | 33 |
Argentina | 33 |
Kawasaki | 33 |
Johnston | 33 |
Genome | 33 |
PIP | 33 |
coronavirus | 33 |
PVM | 33 |
tiene | 33 |
estos | 33 |
dass | 33 |
recomendaciones | 33 |
considerar | 33 |
antigen | 33 |
Tuberculosis | 33 |
RBD | 33 |
Phase | 33 |
Kit | 32 |
Southeast | 32 |
SIRS | 32 |
Prevotella | 32 |
Por | 32 |
Polymerase | 32 |
Orthomyxoviridae | 32 |
Ontario | 32 |
OR | 32 |
CD163 | 32 |
Invitrogen | 32 |
HEp-2 | 32 |
Force | 32 |
Ct | 32 |
Cryptococcus | 32 |
BioFire | 32 |
Ab | 32 |
A(H1N1 | 32 |
TA | 32 |
Studies | 32 |
Consensus | 32 |
TCZ | 32 |
diferentes | 32 |
TSLP | 32 |
sin | 32 |
reducción | 32 |
penton | 32 |
tPA | 32 |
p<0.01 | 32 |
necesario | 32 |
kappaB | 32 |
interferon | 32 |
severidad | 32 |
das | 32 |
association | 32 |
cuando | 32 |
Time | 32 |
amantadine | 32 |
Y | 32 |
así | 32 |
condiciones | 32 |
criterios | 32 |
Royal | 31 |
PDR | 31 |
Robert | 31 |
Regional | 31 |
ROS | 31 |
Program | 31 |
Para | 31 |
PLpro | 31 |
Ig | 31 |
Nasopharyngeal | 31 |
Measles | 31 |
Manual | 31 |
FLU | 31 |
Covid-19 | 31 |
Army | 31 |
SOT | 31 |
SE | 31 |
IGIV | 31 |
Seattle | 31 |
luego | 31 |
traslado | 31 |
síndrome | 31 |
ya | 31 |
subgenomic | 31 |
respuesta | 31 |
plasmacytoid | 31 |
utilización | 31 |
lesión | 31 |
Ventilation | 31 |
efectos | 31 |
Trial | 31 |
Seeplex | 31 |
aa | 31 |
disponibilidad | 31 |
disease | 31 |
ICUs | 30 |
Long | 30 |
Lancet | 30 |
Lactobacillus | 30 |
Jeddah | 30 |
Jartti | 30 |
Institutes | 30 |
HFOV | 30 |
General | 30 |
Falsey | 30 |
Discovery | 30 |
Cameroon | 30 |
Agency | 30 |
Na | 30 |
Egypt | 30 |
MIP-1α | 30 |
Outcomes | 30 |
administration | 30 |
PPV | 30 |
recomendación | 30 |
picornavirus | 30 |
medidas | 30 |
herpes | 30 |
aerosoles | 30 |
mAbs | 30 |
Thomas | 30 |
T. | 30 |
Student | 30 |
Si | 30 |
Qatar | 30 |
Paediatric | 30 |
Creative | 29 |
MA | 29 |
IPS | 29 |
Hoogen | 29 |
Herpes | 29 |
Hendra | 29 |
Hemisphere | 29 |
HLA | 29 |
-3 | 29 |
Council | 29 |
Commons | 29 |
Bio | 29 |
Belgium | 29 |
Assay | 29 |
Aerosol | 29 |
Acinetobacter | 29 |
Pearson | 29 |
PD | 29 |
Co | 29 |
Region | 29 |
hospitalaria | 29 |
SMA | 29 |
rhamnosus | 29 |
qPCR | 29 |
procedimiento | 29 |
nonliquefaciens | 29 |
max | 29 |
−80 | 29 |
plasma | 29 |
consentimiento | 29 |
VP2 | 29 |
complicaciones | 29 |
T4 | 29 |
Team | 29 |
Social | 29 |
VRTI | 29 |
Washington | 29 |
INH | 28 |
Practices | 28 |
PLoS | 28 |
Oseltamivir | 28 |
OPS | 28 |
Neisseria | 28 |
Madagascar | 28 |
MI | 28 |
Interferon | 28 |
IPF | 28 |
IP-10 | 28 |
Anderson | 28 |
IFN- | 28 |
HBoV-3 | 28 |
Golgi | 28 |
GG | 28 |
FluA | 28 |
Family | 28 |
Epstein | 28 |
Article | 28 |
Recommendations | 28 |
AT | 28 |
Project | 28 |
Adult | 28 |
S3 | 28 |
decisión | 28 |
≤ | 28 |
sea | 28 |
refl | 28 |
ng | 28 |
mid | 28 |
inotropic | 28 |
evaluar | 28 |
estándar | 28 |
ensayos | 28 |
disminución | 28 |
solo | 28 |
cytomegalovirus | 28 |
TLRs | 28 |
cm | 28 |
Service | 28 |
Supplementary | 28 |
Survey | 28 |
SAS | 28 |
algunos | 28 |
cada | 28 |
clínicas | 28 |
aérea | 28 |
HI | 27 |
London | 27 |
Interaction | 27 |
Immunology | 27 |
IFNG | 27 |
Hemodynamic | 27 |
Hantavirus | 27 |
HN | 27 |
HIV-1 | 27 |
Foster | 27 |
HFO | 27 |
First | 27 |
FUNDAMENTO | 27 |
Dromedary | 27 |
CRB-65 | 27 |
Azithromycin | 27 |
Allergy | 27 |
-2 | 27 |
M1 | 27 |
Cambodia | 27 |
Microbiol | 27 |
Mg | 27 |
asociada | 27 |
NH | 27 |
tanto | 27 |
square | 27 |
sich | 27 |
pts | 27 |
nsp2 | 27 |
neumonía | 27 |
committee | 27 |
pg | 27 |
alveolar | 27 |
Una | 27 |
TIV | 27 |
Systems | 27 |
PBS | 27 |
Occupational | 27 |
Nucleocapsid | 27 |
Wilcoxon | 27 |
Nosalova | 27 |
Lu | 26 |
GI | 26 |
HTS | 26 |
LDH | 26 |
NHCAP | 26 |
Martin | 26 |
MassTag | 26 |
Mecca | 26 |
Croup | 26 |
GBS | 26 |
AII | 26 |
Comparative | 26 |
Collaborative | 26 |
Choi | 26 |
CD14 | 26 |
British | 26 |
Barr | 26 |
BMC | 26 |
Anyplex | 26 |
AdV | 26 |
Pasteur | 26 |
PONV | 26 |
Parvoviridae | 26 |
Pathology | 26 |
analysis | 26 |
volumen | 26 |
revisión | 26 |
molecule-1 | 26 |
medicamentos | 26 |
laryngotracheobronchitis | 26 |
ist | 26 |
evitar | 26 |
disminuir | 26 |
asthma | 26 |
análisis | 26 |
también | 26 |
Wales | 26 |
Shanghai | 26 |
Testing | 26 |
Randomized | 26 |
Russia | 26 |
Paulo | 26 |
Sigurs | 26 |
Switzerland | 26 |
TCID | 26 |
TMPRSS2 | 26 |
Objectives | 25 |
Expert | 25 |
Interim | 25 |
IL-17 | 25 |
ICS | 25 |
ICH | 25 |
Ho | 25 |
HRCT | 25 |
H&E | 25 |
25 | |
Camels | 25 |
EM | 25 |
DAD | 25 |
Conference | 25 |
Chang | 25 |
CABG | 25 |
BK | 25 |
ATS | 25 |
A1AT | 25 |
Pneumovirinae | 25 |
PIV-2 | 25 |
Methods | 25 |
RH | 25 |
aumento | 25 |
Statistical | 25 |
trabajo | 25 |
teniendo | 25 |
tener | 25 |
sus | 25 |
nach | 25 |
médico | 25 |
información | 25 |
i.v | 25 |
dl | 25 |
parte | 25 |
arterivirus | 25 |
X | 25 |
UAE | 25 |
Tregs | 25 |
Th1 | 25 |
TF | 25 |
Systematic | 25 |
antes | 25 |
Summary | 25 |
Lin | 24 |
HME | 24 |
Hz | 24 |
IPD | 24 |
Inhibition | 24 |
Initiative | 24 |
MM | 24 |
Log | 24 |
MDCK | 24 |
MEGA | 24 |
NPS | 24 |
Nidovirales | 24 |
HCP | 24 |
HIE | 24 |
AR | 24 |
Gram | 24 |
Gern | 24 |
Etiology | 24 |
Esposito | 24 |
Emerg | 24 |
CD26 | 24 |
Bronchoalveolar | 24 |
Bennett | 24 |
BToV | 24 |
ATC | 24 |
ACE-2 | 24 |
A1 | 24 |
-5 | 24 |
PIDD | 24 |
OI | 24 |
Ch | 24 |
Papadopoulos | 24 |
VZV | 24 |
servicios | 24 |
según | 24 |
novo | 24 |
muestras | 24 |
momento | 24 |
mRNAs | 24 |
intranasal | 24 |
intensivo | 24 |
hCoV-229E | 24 |
tomar | 24 |
efecto | 24 |
comité | 24 |
apoyo | 24 |
acuerdo | 24 |
Pathogen | 24 |
VO | 24 |
Seroepidemiology | 24 |
Turkey | 24 |
People | 24 |
Peter | 24 |
Receptor | 24 |
Remdesivir | 24 |
Q | 24 |
Sputum | 24 |
Stata | 24 |
Survanta | 24 |
Swan | 24 |
Tang | 24 |
Th | 24 |
MRNA | 23 |
ID | 23 |
IFI | 23 |
IL-25 | 23 |
Indonesia | 23 |
Laboratories | 23 |
Ltd. | 23 |
MRI | 23 |
NIMV | 23 |
Merkel | 23 |
Microbiome | 23 |
Miller | 23 |
NE | 23 |
NETosis | 23 |
Helsinki | 23 |
NP-1 | 23 |
NP1 | 23 |
Hospitalized | 23 |
EC | 23 |
HCW | 23 |
Guillain | 23 |
AOR | 23 |
AUC | 23 |
Age | 23 |
PB2 | 23 |
Athens | 23 |
BO | 23 |
CCR1 | 23 |
CD | 23 |
Characterization | 23 |
Chile | 23 |
DIC | 23 |
EN | 23 |
Factors | 23 |
FiO2 | 23 |
Ganz | 23 |
Antibodies | 23 |
Organ | 23 |
PF | 23 |
os | 23 |
general | 23 |
hospitalizados | 23 |
importante | 23 |
informado | 23 |
kB | 23 |
kb | 23 |
médica | 23 |
parainfl | 23 |
bronchoscopic | 23 |
pleuropneumoniae | 23 |
renal | 23 |
rimantadine | 23 |
través | 23 |
uno | 23 |
PIV4 | 23 |
þ | 23 |
eventos | 23 |
veces | 23 |
beneficio | 23 |
TGA | 23 |
base | 23 |
Qi | 23 |
Reference | 23 |
Richard | 23 |
SBT | 23 |
Salmonella | 23 |
Spike | 23 |
Plasma | 23 |
Transplant | 23 |
Wallis | 23 |
Wei | 23 |
Williams | 23 |
adversos | 23 |
ammation | 23 |
Un | 23 |
asociado | 23 |
PI | 22 |
Maria | 22 |
Mucosal | 22 |
NO2 | 22 |
Norway | 22 |
PAI-1 | 22 |
PHT | 22 |
Pmus | 22 |
PN | 22 |
PO | 22 |
Pneumovirus | 22 |
Porcine | 22 |
QT | 22 |
RECOMENDACIÓN | 22 |
Intranasal | 22 |
Kruskal | 22 |
Fuerte | 22 |
Inc | 22 |
Carlsbad | 22 |
Actinobacillus | 22 |
Anti | 22 |
Antiviral | 22 |
Background | 22 |
CCL2 | 22 |
RhoA | 22 |
Clinic | 22 |
IG | 22 |
GP4 | 22 |
Guidance | 22 |
H1 | 22 |
HBoV. | 22 |
Hib | 22 |
Huang | 22 |
Rhinitis | 22 |
CVVH | 22 |
SCT | 22 |
sensibilidad | 22 |
frente | 22 |
hospitalización | 22 |
i | 22 |
objetivo | 22 |
presencia | 22 |
rRT | 22 |
septa | 22 |
está | 22 |
significativa | 22 |
simplex | 22 |
stridor | 22 |
tienen | 22 |
viral | 22 |
ST | 22 |
favipiravir | 22 |
requiere | 22 |
estrategias | 22 |
Wark | 22 |
elevación | 22 |
SV | 22 |
Services | 22 |
Spanish | 22 |
Studien | 22 |
Technologies | 22 |
VTM | 22 |
Support | 22 |
adultos | 22 |
aire | 22 |
asociación | 22 |
central | 22 |
crítica | 22 |
debido | 22 |
Int | 21 |
ORF1a | 21 |
JC | 21 |
Lelystad | 21 |
Michael | 21 |
NGS | 21 |
NY | 21 |
Neuraminidase | 21 |
QIAGEN | 21 |
ORFs | 21 |
Openshaw | 21 |
PCA | 21 |
PIPC | 21 |
Pathogens | 21 |
Philippines | 21 |
Presence | 21 |
Immunol | 21 |
Indigenous | 21 |
ALN | 21 |
Hilden | 21 |
COVID | 21 |
-80 | 21 |
SM | 21 |
Application | 21 |
Aspiration | 21 |
BIII | 21 |
Broad | 21 |
CCL3 | 21 |
Candida | 21 |
Hepatitis | 21 |
Child | 21 |
Croatia | 21 |
Cross | 21 |
Duchenne | 21 |
Fischer | 21 |
Frequency | 21 |
HAP | 21 |
SIV | 21 |
Replication | 21 |
Sigma | 21 |
p<0.05 | 21 |
immunoprophylaxis | 21 |
invasiva | 21 |
medición | 21 |
mejor | 21 |
muestra | 21 |
necesidad | 21 |
neutrophilia | 21 |
parechovirus | 21 |
establecer | 21 |
pleuritis | 21 |
presenta | 21 |
reanimación | 21 |
siguientes | 21 |
toma | 21 |
tratados | 21 |
−1 | 21 |
hyperimmune | 21 |
~s | 21 |
escala | 21 |
Valencia | 21 |
ein | 21 |
Spearman | 21 |
Survival | 21 |
São | 21 |
Tanzania | 21 |
Thermo | 21 |
Treg | 21 |
SpO | 21 |
Wright | 21 |
Zhao | 21 |
ante | 21 |
anticuerpos | 21 |
carga | 21 |
críticamente | 21 |
Young | 21 |
echovirus | 21 |
MAC | 20 |
Fever | 20 |
Garcia | 20 |
HP | 20 |
Hypoxemia | 20 |
IBM | 20 |
Karron | 20 |
Lao | 20 |
NI | 20 |
NAAT | 20 |
NC | 20 |
Nieman | 20 |
OX40 | 20 |
Objective | 20 |
PIV-4 | 20 |
FEF | 20 |
PIV2 | 20 |
Failure | 20 |
Bacteroides | 20 |
Emerging | 20 |
Eastern | 20 |
POC | 20 |
-6 | 20 |
3C | 20 |
AAD | 20 |
Adenoviral | 20 |
Alaska | 20 |
Ann | 20 |
BRDC | 20 |
BW | 20 |
CHF | 20 |
CLDM | 20 |
CXCL8 | 20 |
Chung | 20 |
Dept | 20 |
Early | 20 |
PLWH | 20 |
rutinaria | 20 |
PV | 20 |
dificultad | 20 |
factores | 20 |
frecuencia | 20 |
gestión | 20 |
le | 20 |
mPCR | 20 |
mmol | 20 |
prueba | 20 |
punto | 20 |
retrospectivo | 20 |
rhinovirus | 20 |
sedación | 20 |
siendo | 20 |
tasa | 20 |
PVR | 20 |
Ò | 20 |
estado | 20 |
residuos | 20 |
calidad | 20 |
Sequencing | 20 |
Quality | 20 |
cDNA | 20 |
Quebec | 20 |
ROX | 20 |
RSVB | 20 |
Rosa | 20 |
SHIVERS | 20 |
Peiris | 20 |
auf | 20 |
Taq | 20 |
Veterinary | 20 |
Yang | 20 |
Yu | 20 |
Subbarao | 20 |
agudo | 20 |
Israel | 19 |
Microsoft | 19 |
Matrix | 19 |
MR | 19 |
Lanzhou | 19 |
Lau | 19 |
Latin | 19 |
Kuala | 19 |
NAT | 19 |
Joint | 19 |
Note | 19 |
NIRS | 19 |
NL | 19 |
NZ | 19 |
Nebulized | 19 |
Nguyen | 19 |
Nosocomial | 19 |
Nucleic | 19 |
Oman | 19 |
PMN | 19 |
Hirsch | 19 |
Ireland | 19 |
Brisbane | 19 |
HeLa | 19 |
Crit | 19 |
Paw | 19 |
16S | 19 |
Adenoviridae | 19 |
Alveolar | 19 |
Angiotensin | 19 |
Australian | 19 |
CV | 19 |
Cohort | 19 |
Copan | 19 |
Cs | 19 |
HBoV-2 | 19 |
Cytomegalovirus | 19 |
Diego | 19 |
Doppler | 19 |
ERS | 19 |
Ethical | 19 |
Ethiopia | 19 |
FAST | 19 |
Genomic | 19 |
Green | 19 |
PaCO2 | 19 |
Curosurf | 19 |
Picornavirus | 19 |
incluyendo | 19 |
curso | 19 |
dentro | 19 |
desenlaces | 19 |
deterioro | 19 |
einem | 19 |
eines | 19 |
enfermo | 19 |
evaluaron | 19 |
evolución | 19 |
nicht | 19 |
contexto | 19 |
otras | 19 |
presentaron | 19 |
remdesivir | 19 |
rutina | 19 |
sistema | 19 |
st | 19 |
virologic | 19 |
| 19 |
Progress | 19 |
coxsackievirus | 19 |
grupos | 19 |
camas | 19 |
SpO2 | 19 |
Wellemans | 19 |
RSV01 | 19 |
RV15 | 19 |
Rad | 19 |
Rehabilitation | 19 |
Reverse | 19 |
Reye | 19 |
Scotland | 19 |
Shah | 19 |
Smith | 19 |
ST2 | 19 |
W. | 19 |
Statistics | 19 |
T1 | 19 |
TLR7 | 19 |
Tracheal | 19 |
VP4 | 19 |
Verigene | 19 |
W | 19 |
St. | 19 |
Jin | 18 |
MCP-1 | 18 |
MAS | 18 |
Lumpur | 18 |
Lebanon | 18 |
Idaho | 18 |
Jet | 18 |
Innate | 18 |
Infl | 18 |
MDA5 | 18 |
MCPyV | 18 |
Physiology | 18 |
MTB | 18 |
Master | 18 |
Metagenomic | 18 |
Microbiota | 18 |
Mouse | 18 |
Murray | 18 |
NAC | 18 |
Nasal | 18 |
PCO | 18 |
PP | 18 |
Han | 18 |
Hematopoietic | 18 |
ANP | 18 |
HPS | 18 |
HPIV1 | 18 |
Predictors | 18 |
ASA | 18 |
AST | 18 |
Access | 18 |
Activation | 18 |
Antimicrobial | 18 |
Beatmung | 18 |
Bronchiectasis | 18 |
ClinicalTrials.gov | 18 |
Corynebacterium | 18 |
County | 18 |
Denmark | 18 |
Division | 18 |
E6 | 18 |
EB | 18 |
Echovirus | 18 |
Epidemiological | 18 |
FluB | 18 |
Front | 18 |
Fusobacterium | 18 |
HAdV-4 | 18 |
Post | 18 |
Promega | 18 |
Prism | 18 |
protocolo | 18 |
función | 18 |
genera | 18 |
hallazgos | 18 |
inflammasome | 18 |
key | 18 |
manifestaciones | 18 |
marzo | 18 |
mediante | 18 |
pHi | 18 |
perfusión | 18 |
protocolos | 18 |
final | 18 |
requieren | 18 |
retiro | 18 |
review | 18 |
rhinosinusitis | 18 |
rt | 18 |
serologic | 18 |
significativamente | 18 |
tracheitis | 18 |
unidades | 18 |
wird | 18 |
fuera | 18 |
sistemática | 18 |
enfermos | 18 |
Wu | 18 |
elementos | 18 |
Scale | 18 |
T2 | 18 |
T3 | 18 |
T5 | 18 |
TSH | 18 |
Texas | 18 |
Upper | 18 |
VEGF | 18 |
Walsh | 18 |
Seroprevalence | 18 |
Zhou | 18 |
cient | 18 |
edad | 18 |
adecuado | 18 |
droperidol | 18 |
duración | 18 |
cation | 18 |
adenoviral | 18 |
cambios | 18 |
als | 18 |
HADV | 17 |
HPIV-1 | 17 |
Humans | 17 |
Hydroxychloroquine | 17 |
IHC | 17 |
Immunity | 17 |
Incidence | 17 |
Italia | 17 |
KIPyV | 17 |
MOSF | 17 |
LDV | 17 |
Primary | 17 |
Mina | 17 |
Mix | 17 |
NALT | 17 |
Nature | 17 |
Nutrition | 17 |
PH | 17 |
PRISMA | 17 |
French | 17 |
Genetics | 17 |
CDH | 17 |
Excel | 17 |
CC | 17 |
Proteobacteria | 17 |
AIII | 17 |
ALRTI | 17 |
Advanced | 17 |
Arden | 17 |
Austria | 17 |
Britain | 17 |
C2 | 17 |
CD3 | 17 |
Education | 17 |
CIS | 17 |
CRL1505 | 17 |
Cas9 | 17 |
CoV-1 | 17 |
DMD | 17 |
Defense | 17 |
Douglas | 17 |
EF | 17 |
Protective | 17 |
seguimiento | 17 |
Protocol | 17 |
humano | 17 |
intervenciones | 17 |
jirovecii | 17 |
multiorgan | 17 |
nd | 17 |
p<0,05 | 17 |
pDCs | 17 |
phi | 17 |
pleconaril | 17 |
posterior | 17 |
proceso | 17 |
procesos | 17 |
pyothorax | 17 |
replicase | 17 |
reportaron | 17 |
spp | 17 |
teno | 17 |
términos | 17 |
unidad | 17 |
Sly | 17 |
hypercapnic | 17 |
siRNA | 17 |
hematogenous | 17 |
Windows | 17 |
St | 17 |
fase | 17 |
Station | 17 |
TT | 17 |
Task | 17 |
Turku | 17 |
Ventilator | 17 |
Victoria | 17 |
TPN | 17 |
Wisconsin | 17 |
evaluación | 17 |
auch | 17 |
aún | 17 |
después | 17 |
enfermedades | 17 |
extubación | 17 |
esto | 17 |
Zanamivir | 17 |
JAK | 16 |
Information | 16 |
Immunohistochemical | 16 |
Illumina | 16 |
ISAAC | 16 |
IRB | 16 |
Heliox | 16 |
INO | 16 |
Histopathologic | 16 |
Hexaplex | 16 |
HS | 16 |
H9N2 | 16 |
H1N1pdm09 | 16 |
Lymphopenia | 16 |
Guideline | 16 |
Johnson | 16 |
Makkah | 16 |
López | 16 |
NCBI | 16 |
GVHD | 16 |
Pattern | 16 |
Paris | 16 |
Pacific | 16 |
PRRs | 16 |
PCP | 16 |
Mechanical | 16 |
MARC-145 | 16 |
Ma | 16 |
MVI | 16 |
MVA | 16 |
MS2 | 16 |
MP | 16 |
MERS- | 16 |
Gerna | 16 |
BoHV-1 | 16 |
Firmicutes | 16 |
Ali | 16 |
COVID‐19 | 16 |
BioMed | 16 |
Baxter | 16 |
Bastien | 16 |
BV | 16 |
Arteriviridae | 16 |
Adv | 16 |
Figs | 16 |
Abstract | 16 |
AV | 16 |
AP | 16 |
AFRI | 16 |
-8 | 16 |
RCTs | 16 |
Cells | 16 |
Chain | 16 |
Chan | 16 |
Cluster | 16 |
Complex | 16 |
Congo | 16 |
Consultation | 16 |
Contribution | 16 |
CpG | 16 |
Crystal | 16 |
DoD | 16 |
Dyspnea | 16 |
ECP | 16 |
EHV-1 | 16 |
Expression | 16 |
Favipiravir | 16 |
FiO | 16 |
Probe | 16 |
ESBL | 16 |
RRR | 16 |
ensayo | 16 |
nasal | 16 |
n=10 | 16 |
muy | 16 |
leve | 16 |
implementación | 16 |
existe | 16 |
disponible | 16 |
palatine | 16 |
dem | 16 |
daño | 16 |
−/− | 16 |
controles | 16 |
contaminación | 16 |
complejidad | 16 |
ningún | 16 |
parainfluenzavirus | 16 |
china | 16 |
siempre | 16 |
− | 16 |
° | 16 |
zur | 16 |
valoración | 16 |
trabajadores | 16 |
suficiente | 16 |
riesgos | 16 |
pleuropneumonia | 16 |
respiratorias | 16 |
reducir | 16 |
pruebas | 16 |
prono | 16 |
probabilidad | 16 |
pos | 16 |
comparado | 16 |
RS | 16 |
capacidad | 16 |
Schwarze | 16 |
Standards | 16 |
Spirometry | 16 |
Spectrum | 16 |
Single | 16 |
Shannon | 16 |
Sect | 16 |
SVR | 16 |
StataCorp | 16 |
SLS | 16 |
SDD | 16 |
Reynolds | 16 |
Rev | 16 |
Recombination | 16 |
cacy | 16 |
Staph | 16 |
Section | 16 |
Strategy | 16 |
Zaki | 16 |
TOF | 16 |
bronchogram | 16 |
anti | 16 |
anterior | 16 |
alteraciones | 16 |
adecuada | 16 |
amplifi | 16 |
Xu | 16 |
cGMP | 16 |
VO2 | 16 |
Universal | 16 |
Tropical | 16 |
Tran | 16 |
INF | 15 |
Lopinavir | 15 |
Le | 15 |
Lab | 15 |
LT | 15 |
LC | 15 |
Jean | 15 |
Grant | 15 |
IMV | 15 |
Hb | 15 |
HPIV-3 | 15 |
HBOV | 15 |
HAdV-1 | 15 |
GraphPad | 15 |
MIC | 15 |
MBL | 15 |
Paragonimus | 15 |
Marrow | 15 |
OM-85 | 15 |
GZ9081 | 15 |
PGI2 | 15 |
PB | 15 |
Open | 15 |
Office | 15 |
OVA | 15 |
Non | 15 |
Martinez | 15 |
Nigeria | 15 |
Naples | 15 |
NT | 15 |
Monto | 15 |
Model | 15 |
Minh | 15 |
Graham | 15 |
Cl | 15 |
GP3 | 15 |
Attribution | 15 |
CD40 | 15 |
CCR2 | 15 |
CCA | 15 |
Bronchodilators | 15 |
Biologics | 15 |
B14 | 15 |
Antonio | 15 |
CP | 15 |
Amiodarone | 15 |
ATCC | 15 |
ADM | 15 |
ACT | 15 |
-4 | 15 |
Persistence | 15 |
CHD | 15 |
Cary | 15 |
Frühgeborenen | 15 |
EMCO | 15 |
Fc | 15 |
Experimental | 15 |
Esto | 15 |
Englund | 15 |
Elsevier | 15 |
EMS | 15 |
EDs | 15 |
Cdyn | 15 |
Dipeptidyl | 15 |
Delta | 15 |
Declaration | 15 |
Database | 15 |
Cq | 15 |
Consortium | 15 |
Paul | 15 |
Murphy | 15 |
Philadelphia | 15 |
aplicación | 15 |
health | 15 |
hacer | 15 |
grave | 15 |
expertos | 15 |
estancia | 15 |
equi | 15 |
entrenamiento | 15 |
emitir | 15 |
eSensor | 15 |
diffi | 15 |
datos | 15 |
corona | 15 |
contigs | 15 |
cardiovasculares | 15 |
cardiovascular | 15 |
herramienta | 15 |
inicial | 15 |
insuficiencia | 15 |
situaciones | 15 |
Phylogenetic | 15 |
× | 15 |
zooepidemicus | 15 |
traqueostomía | 15 |
tiempos | 15 |
somni | 15 |
rendimiento | 15 |
interleukin-6 | 15 |
recurso | 15 |
realizaron | 15 |
primera | 15 |
pp1a | 15 |
personas | 15 |
monitoreo | 15 |
bolsa | 15 |
nos | 15 |
a1111111111 | 15 |
RD | 15 |
Scholar | 15 |
Rotterdam | 15 |
Role | 15 |
RespiFinder | 15 |
Ref | 15 |
Recognition | 15 |
Qs | 15 |
Springer | 15 |
Pts | 15 |
Prospective | 15 |
Pro | 15 |
Pneumonias | 15 |
Zhu | 15 |
Pilot | 15 |
Software | 15 |
RSVA | 15 |
Tecumseh | 15 |
Transplantation | 15 |
Yamagata | 15 |
Territory | 15 |
Xiao | 15 |
V~ | 15 |
Vabret | 15 |
VMNI | 15 |
VA | 15 |
VSV | 15 |
Transcription | 15 |
Tract | 15 |
Track | 15 |
Torque | 15 |
Test | 15 |
Z | 15 |
Kaiser | 14 |
Immunogenicity | 14 |
Korpas | 14 |
Lake | 14 |
Jan | 14 |
James | 14 |
Intravenous | 14 |
Intracellular | 14 |
Institut | 14 |
Inhibitors | 14 |
Humoral | 14 |
Imaging | 14 |
ITU | 14 |
IPC | 14 |
IL-11 | 14 |
IFVA | 14 |
Hutchison | 14 |
Hospitals | 14 |
Histophilus | 14 |
Light | 14 |
HbSS | 14 |
HbAA | 14 |
Leung | 14 |
Nonstructural | 14 |
MEDI-493 | 14 |
Neutrophils | 14 |
HPIV3 | 14 |
PSI | 14 |
PKR | 14 |
PImax | 14 |
PEF | 14 |
PCWP | 14 |
P3 | 14 |
Nocardia | 14 |
Nichols | 14 |
NPAs | 14 |
MHV | 14 |
NNT | 14 |
NADC30-like | 14 |
N2 | 14 |
N-95 | 14 |
Mononegavirales | 14 |
Mechanism | 14 |
Measurement | 14 |
Maela | 14 |
MLV | 14 |
HPV | 14 |
Basic | 14 |
HES | 14 |
BIPAP | 14 |
Chiu | 14 |
Chemokines | 14 |
Chemokine | 14 |
Chemaly | 14 |
CRISPR | 14 |
C57BL/6 | 14 |
Burkholderia | 14 |
Betacoronavirus | 14 |
BMI | 14 |
Arterivirus | 14 |
Coinfections | 14 |
Apache | 14 |
Alveolen | 14 |
Aetiology | 14 |
Activity | 14 |
Accepted | 14 |
ATP | 14 |
AMPC | 14 |
AFE | 14 |
Patienten | 14 |
Cleveland | 14 |
Colombia | 14 |
HAdV-2 | 14 |
Epidemic | 14 |
Geneva | 14 |
Garofalo | 14 |
Gansu | 14 |
GSH | 14 |
GRU | 14 |
GC | 14 |
Estos | 14 |
Esta | 14 |
Epidemiologic | 14 |
Enterobacteriaceae | 14 |
Correlation | 14 |
ERK | 14 |
Dictyocaulus | 14 |
Deng | 14 |
Delphi | 14 |
David | 14 |
Darwin | 14 |
Crs | 14 |
Crowe | 14 |
Coyle | 14 |
Park | 14 |
ha | 14 |
Performance | 14 |
intensivista | 14 |
mostró | 14 |
metas | 14 |
mental | 14 |
mannheimiosis | 14 |
kommt | 14 |
jedoch | 14 |
investigación | 14 |
intraalveolar | 14 |
interleukin-4 | 14 |
inmunoglobulina | 14 |
pneumoconiosis | 14 |
immunoassays | 14 |
i.p | 14 |
hydroxychloroquine | 14 |
hematoxylin | 14 |
fibrinous | 14 |
exposición | 14 |
están | 14 |
equipos | 14 |
enfermería | 14 |
nutrición | 14 |
pneumonia | 14 |
cánula | 14 |
todo | 14 |
Prince | 14 |
≥ | 14 |
útil | 14 |
áreas | 14 |
ventilatorio | 14 |
valores | 14 |
ts | 14 |
trimethoprim | 14 |
tratamientos | 14 |
temprana | 14 |
posibilidad | 14 |
submucosal | 14 |
spirometry | 14 |
species | 14 |
sind | 14 |
series | 14 |
protein-1 | 14 |
profesionales | 14 |
primer | 14 |
prevención | 14 |
documento | 14 |
myalgia | 14 |
covid-19 | 14 |
Th17 | 14 |
Target | 14 |
Tabla | 14 |
TTW | 14 |
TISS | 14 |
TIMP-1 | 14 |
TE | 14 |
TAZ | 14 |
Synthesis | 14 |
Stokes | 14 |
Sepsis | 14 |
Scopus | 14 |
Salt | 14 |
SaO | 14 |
SEM | 14 |
SCID | 14 |
Rome | 14 |
Ray | 14 |
ROB | 14 |
Queensland | 14 |
contagio | 14 |
Principles | 14 |
Taylor | 14 |
Sudan | 14 |
Th2-type | 14 |
asociados | 14 |
condición | 14 |
classifi | 14 |
clarithromycin | 14 |
chemoprophylaxis | 14 |
caso | 14 |
cardiaca | 14 |
bronchopneumonias | 14 |
biomarcadores | 14 |
aumentar | 14 |
cohorte | 14 |
YK | 14 |
Xpert | 14 |
Waghmare | 14 |
Turner | 14 |
Tokyo | 14 |
Tocilizumab | 14 |
Tissue | 14 |
Therapie | 14 |
Thai | 14 |
Jacobs | 13 |
Identifi | 13 |
Instituto | 13 |
Integrated | 13 |
Jackson | 13 |
Louis | 13 |
Kinetics | 13 |
Listeria | 13 |
IPPV | 13 |
MBP | 13 |
IU | 13 |
Holt | 13 |
ILC2s | 13 |
ILC2 | 13 |
IDSA | 13 |
Hubei | 13 |
Mackay | 13 |
Hayden | 13 |
Haematological | 13 |
HMGB1 | 13 |
HF | 13 |
HEPA | 13 |
HCOV | 13 |
MODS | 13 |
Poly | 13 |
Mandell | 13 |
Mannheim | 13 |
PyVs | 13 |
Girard | 13 |
Pneumoviridae | 13 |
Pleconaril | 13 |
Platinum | 13 |
Pdi | 13 |
Part | 13 |
PT | 13 |
PAV | 13 |
PAM | 13 |
Ogimi | 13 |
ORF8 | 13 |
O | 13 |
Neonatal | 13 |
NO3 | 13 |
NIH | 13 |
NG | 13 |
NASBA | 13 |
NAATs | 13 |
Melbourne | 13 |
Matthew | 13 |
H7N7 | 13 |
ACIP | 13 |
GS-5734 | 13 |
Assembly | 13 |
CQ | 13 |
CD18 | 13 |
C1 | 13 |
Boston | 13 |
Boca | 13 |
Belshe | 13 |
Bei | 13 |
Bacteroidetes | 13 |
Australians | 13 |
Atlanta | 13 |
Anwendung | 13 |
Fred | 13 |
Ankara | 13 |
Am | 13 |
Ahmed | 13 |
Acquired | 13 |
Abbott | 13 |
ADMA | 13 |
ADE | 13 |
AC | 13 |
AAP | 13 |
SB | 13 |
Ca | 13 |
Calmette | 13 |
Cambodian | 13 |
Carlo | 13 |
Fox | 13 |
Fi02 | 13 |
Faculty | 13 |
FM | 13 |
FIO2 | 13 |
Exposure | 13 |
Exosurf | 13 |
Erles | 13 |
English | 13 |
ECM | 13 |
Drosten | 13 |
D3 | 13 |
Cytokines | 13 |
Coxsackie | 13 |
Corticosteroids | 13 |
Corporation | 13 |
Cook | 13 |
Club | 13 |
Chemotherapy | 13 |
Cellular | 13 |
Carlos | 13 |
Res | 13 |
TLR-4 | 13 |
SIGN | 13 |
ketoconazole | 13 |
neg | 13 |
n=6 | 13 |
médicos | 13 |
moderado | 13 |
midazolam | 13 |
mayores | 13 |
mayo | 13 |
mascarilla | 13 |
lobar | 13 |